Human Granzyme A Antibody, R&D Systems™

Granzyme A

LYOPH

Western Blot

Unconjugated

Mouse

Human

P12544

3001

Mouse myeloma cell line NS0-derived recombinant human Granzyme A Cys26-Val262 Accession # P12544

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human Granzyme A in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) Granzyme B, rhGranzyme H, recombinant mouse (rm) Granzyme D, or rmGranzyme G is observed.

356422

Western Blot 2 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CTL tryptase, CTLA3, CTLA3Granzyme A (Cytotoxic T-lymphocyte-associated serine esterase-3; Hanukah factorserine protease), Cytotoxic T-lymphocyte proteinase 1, EC 3.4.21, fragmentin-1, granzyme A, granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3), Granzyme-1, GZMA, H factor, Hanukkah factor, HF, HFSP, HFSPEC 3.4.21.78

GZMA

IgG1

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.